GeneDx Recognizes Cerebral Palsy Awareness Month with Commitment to Improve Access to Testing GAITHERSBURG, Md.--(BUSINESS WIRE)-- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes ...

Patients reveal persistent gaps in genetic testing, diagnosis, and clinical trial access—and implications for advancing ...

STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a new way to provide genetic counseling and ...

Jaguar Gene Therapy joins as founding partner to initiate a genetic testing program for SHANK3-related autism spectrum disorder and Phelan-McDermid syndrome GAITHERSBURG, Md.--(BUSINESS WIRE)-- GeneDx ...

-- A milestone in pediatric medicine, general pediatricians are now expected to play a more active role in initiating genetic testing -- -- Earlier use of exome and genome testing delivers better ...

Please provide your email address to receive an email when new articles are posted on . Standard care relies on physicians suspecting genetic diseases in infants and referring them for testing. An ...

President and CEO Katherine Stueland stated that GeneDx achieved significant milestones in 2024, including surpassing $95 million in Q4 revenue and expanding gross margins to 70%. She highlighted the ...

BOSTON--(BUSINESS WIRE)--Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding for their Whole Genome Sequencing (WGS)-based testing ...

Editor's Note: This interview is part of an ongoing Star series highlighting Kansas Citians from historically underrepresented communities and their impact on our region. The series builds on The Star ...